Acceleron Pharma
XLRN
#1878
Rank
A$15.69 B
Marketcap
A$256.68
Share price
0.00%
Change (1 day)
13,265.47%
Change (1 year)

Market capitalization of Acceleron Pharma (XLRN)

Last known market cap: A$15.69 Billion

As of February 2026 Acceleron Pharma has a market cap of A$15.69 Billion. This makes Acceleron Pharma the world's 1878th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Acceleron Pharma from 2013 to 2022

End of year Market Cap

Year Marketcap Change
2022A$16.06 B6.54%
2021A$15.07 B50.41%
2020A$10.02 B149.2%
2019A$4.02 B40.67%
2018A$2.85 B16.3%
2017A$2.45 B84.01%
2016A$1.33 B-40.07%
2015A$2.22 B44.42%
2014A$1.54 B22.68%
2013A$1.25 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
A$786.22 B 4,908.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$215.87 B 1,275.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$264.36 B 1,584.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$112.84 B 618.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
A$0.25 B-98.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
A$30.01 M-99.81%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
A$69.88 M-99.55%๐Ÿ‡บ๐Ÿ‡ธ USA